LIGHTBRIDGE Corp LTBR Cash Flow

Lightbridge corp (LTBR)

CashFlow / Quarterly

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11
Operating Activities:
Net Loss
-2,264	-1,728	-2,441	-3,306	-3,110	-3,223	-4,214	-3,517	-4,721	-1,988	-1,733	-1,637	-1,745	-3,209	-1,503	-1,297	-334	-3,241	-174	-1,020	117	1,409	95	-1,751	-3,408	-965	-1,319	-1,023	-1,278	-697	-1,247	-1,314	-796	-1,899	-1,168	-1,161	-1,638
Adjustments to reconcile net loss from operations to net cash used in operating activities:
Stock-based compensation
6	231	19	237	335	428	529	148	1,273	594	170	198	229	1,040	392	365	185	863	235	700	81	55	101	65	59	55	62	63	147	144	202	277	350	365	362	380	404
Amortization of deferred financing cost
-	-	-	-	-	-	-	-	-	122	122	122	122	122	68	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Write off of deferred financing costs
-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Equity in loss from joint venture
-	-	-	-	-1,295	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Depreciation and amortization
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2	2	6	6	6	7	8	6	7	5	6	7
Loss on marketable securities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-1	-0	0	0	0	-3	-42	-3	53	32	21	87	-14	22	123	-37
Warrant revaluation
-	-	-	-	-	-	-	-	-	-	-	-	-	28	78	311	1,253	-435	1,083	460	1,197	2,375	857	-96	-1,974	-	-	-	-	-	-	-	-	-	-	-	-
Write off of deferred financing costs
-	-	-	-	-	-	-	0	982	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Equity in loss from joint venture
-	-	-	-	-	-	-	-3,830	1,028	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Changes in operating working capital items:
Accounts receivable - fees and reimbursable project costs
-	-	-	-	-	0	0	0	10	751	4	-76	-300	305	13	-83	13	-115	7	-71	-150	331	-270	-99	81	-202	-34	245	-183	181	-243	-260	648	-560	-452	385	-85
Other receivable from joint venture
400	-	-	-	-265	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Prepaid expenses and other current assets
-297	-	-	-	-157	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accounts payable and accrued liabilities
135	-	-	-	356	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other receivable from joint venture
-	-	-	-	-	-	-106	73	-488	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other receivable from joint venture
-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Prepaid expenses and other current assets
-	-	-	-	-	-	-13	38	-76	-5	-33	-33	84	-54	-54	-286	308	55	-91	-115	114	-95	-38	-122	172	-159	-72	-184	131	-132	71	176	67	-126	-416	-383	830
Accounts payable and accrued liabilities
-	-	-	-	-	-	-16	113	140	-4	212	-126	78	263	-392	-273	505	337	155	-134	-66	264	-465	218	160	194	-140	29	8	-709	164	-481	-268	325	-52	-423	-188
Deferred lease abandonment liability
-	-	-	-	-	-	-	-	-	-254	-3	30	42	64	44	59	95	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred revenue
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-578	-356	837
Net Cash Used In Operating Activities
-2,019	-2,550	-1,208	-1,362	-1,546	-2,122	-2,077	-1,368	-1,851	-1,415	-1,084	-1,362	-1,140	-2,067	-1,517	-1,076	-1,314	-1,111	-783	-727	-1,029	-881	-815	-1,149	-1,469	-627	-1,283	-942	-1,061	-1,359	-733	-1,448	-1,511	-499	-584	-1,680	-1,285
Investing Activities:
Investment in joint venture
-	-	-	-	-1,440	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Investment in joint venture
-	-	-	-	-	-	0	-10,434	5,217	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Patent costs
-4	-	-	-	-108	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Investment in joint venture
-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from the sale of marketable securities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-160	8,635	-16	1,949
Purchase of marketable securities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	5	14	17	-7	120	58	63	5,000	0	0	0
Purchase of property and equipment
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0	0	1
Patent costs
-	-	-	-	-	-	-	-233	94	47	44	72	42	38	73	36	61	57	9	30	19	32	36	39	26	26	-1	38	34	20	4	10	28	54	60	23	21
Net Cash Used In Investing Activities
-4	-72	-19	-2,120	-1,548	-437	-33	-44	-5,311	-47	-44	-72	-42	-38	-73	-36	-61	-57	-9	-30	-19	-17	-36	-39	-26	-27	1,068	446	-52	2,987	476	309	-91	-5,215	8,575	-39	1,926
Financing Activities:
Net proceeds from the issuance of common stock
399	-	-	-	1,986	-	-	-	20,722	1,650	1,350	212	2,813	2,504	640	1,595	1,396	116	55	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net proceeds from the issuance of preferred stock
-	-	-	-	-	-	-	-	3,900	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from the issuance of note payable
-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	135	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Repayment of note payable
-	-	-	-	-	-	-	-	-	-	-	-	-	27	40	40	26	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Restricted cash
-	-	-	-	-	-	-	-	-	-	-	-	0	0	78	-290	0	0	0	0	0	-230	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Cash Provided by Financing Activities
399	0	834	929	1,986	1,869	1,731	5,146	24,622	1,764	1,350	212	2,813	2,476	3,320	1,845	1,504	116	97	-42	-0	4,678	305	-0	-0	3,965	-8	-0	-0	-0	-0	1	-0	-0	-0	-0	-0
Net Decrease In Cash and Cash Equivalents
-1,624	-2,622	-393	-2,552	-1,109	-691	-378	3,733	17,458	301	222	-1,222	1,630	370	1,729	732	128	-1,052	-695	-800	-1,048	3,779	-547	-1,189	-1,495	3,310	-223	-496	-1,114	1,628	-258	-1,138	-1,603	-5,715	7,990	-1,720	640
Cash and Cash Equivalents, Beginning of Period
17,958	-	-	-	24,637	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents, End of Period
16,334	-	-	-	23,528	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash paid during the year
Interest paid
-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Income taxes paid
-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Non-Cash Financing Activities:
Deemed dividend on Series B convertible preferred stock due to beneficial conversion feature
-	-	-	-	-	-	-	-	2,624	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accumulated preferred stock dividend
180	177	176	173	172	315	119	70	144	129	49	49	49	47	32	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Conversion of Series A convertible preferred stock to common stock and payment of paid-in-kind dividends to Series A preferred stockholder
8	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Decrease in accrued liabilities - stock-based compensation
-	-	-	-	-	-	-	-	-	0	0	0	121	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-